Bbid contains Pancreatin. Bbid uses:
In the conditions with defcient pancreatic exocrine function such as-
|Therapeutic Class:||Digestive Enzyme|
|Manufacturer:||KONVERGE HEALTHCARE PRIVATE LIMITED|
|Last Updated:||2020-11-20 18:15:00|
Bbid contains Pancreatin 192.0 Mg. Bbid doses
1-3 tablets daily with meal or as per direction of the physician.
Bbid may cause buccal and perianal soreness, particularly in infants. Hypersensitivity reactions have been reported; these may be sneezing, lacrimation or skin rashes.
Bbid is a preparation of Bbid having protease, lipase and amylase enzyme activity. Bbid hydrolyses fats to glycerol and fatty acids, changes protein into proteoses and derived substances and converts starch into dextrins and sugars. Bbid is employed in the conditions where the secretion of pancreatic juice is defcient.
A proper balance between fat, protein and starch intake must be maintained to avoid temporary indigestion.
Alkaline media will rupture the enteric coating. As such to prevent bursting out of the content in the stomach Bbid should not be used concurrently with antacid.
Pregnancy category C. Not known whether Bbid is distributed into milk. Caution advised if Bbid is used.
Excessive dosage may produce a laxative efect. Systemic toxicity does not occur. Very high dosage may cause hyperuricemia and hyperuricos-uria.
Store in a cool and dry place. Keep out of the reach of children.
Bbid Tablet price in India 0